Overdiagnosis: How cancer screening can turn indolent pathology into illness

APMIS

Volumn 122, Issue 8, 2014, Pages 683-689

  Brodersen, John ^a   Schwartz, Lisa M ^b,c   Woloshin, Steven ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Illness; Overdiagnosis; Prevention; Screening

Indexed keywords

INFLUENZA VACCINE; PROSTATE SPECIFIC ANTIGEN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; COLON CANCER; DISEASE COURSE; HUMAN; INDOLENT PATHOLOGY; INFLUENZA VACCINATION; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; OCCULT BLOOD; PAPANICOLAOU TEST; PATHOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION; REVIEW; SECONDARY PREVENTION; UTERINE CERVIX CANCER; WART VIRUS;

CANCER; ILLNESS; OVERDIAGNOSIS; PREVENTION; SCREENING;

DIAGNOSTIC ERRORS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; NEOPLASMS;

EID: 84904556898     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12278     Document Type: Review

References (13)

1. Shorter E. Doctor's and their Patients: A Social History. New Brunswick, NJ: Simon and Schuster, 1985.
2. Bentzen N. Wonca Dictionary of General/Family Practice. Copenhagen: Månedsskrift for Praktisk Lægergerning, 2003.
3. Wijnans L, Lecomte C, De Vries C, Weibel D, Sammon C, Hviid A, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-54.
4. Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Family Med 2013;11:106-15.
5. Greene HL, Roden DM, Katz RJ, Woosley RL, Salerno DM, Henthorn RW. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II. J Am Coll Cardiol 1992;19:894-8.
6. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989;321:406-12.
7. Welch HG, Schwartz L, Woloshin S. Overdiagnosed. Making People Sick in the Pursuit of Health. Boston: Beacon Press, 2011.
8. National Cancer Institute. Surveillance, Epidemiology, and End Results Program (SEER). Cancer Query Systems. 2014. Available at http://seer.cancer.gov/canques/ (accessed 18 January 2014).
9. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006;332:689-92.
10. Patz EF Jr, Pinsky P, Gatsonis C. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2013. doi: 10.1001/jamainternmed.2013.12738.
11. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012;366:981-90.
12. Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101:374-83.
13. Raffle A, Gray M. Screening: Evidence and Practice. Oxford: Oxford University Press, 2007.